德孚在中国

9 4 3 6 4

论文已发表

提 交 论 文


注册即可获取德孚的最新动态

注 册



IF 收录期刊





更多详情 >>





已发表论文

SA12（一种新的多肽）通过线粒体凋亡途径产生的对 SKBr-3 乳腺癌细胞的抗肿瘤活性

 

Authors Yang L, Cui Y, Shen J, Lin F, Wang X, Long M, Wei J, Zhang H

Published Date March 2015 Volume 2015:9 Pages 1319—1330

DOI http://dx.doi.org/10.2147/DDDT.S75780

Received 14 October 2014, Accepted 2 December 2014, Published 2 March 2015

Abstract: Breast cancer is considered to be the most common malignancy in women. Treatment of breast cancer has been focused on molecular targeted therapy, and anticancer peptides are considered to be some of the most promising candidate drugs. In the current study, we used mRNA-peptide display technology to screen antibreast cancer peptides and identified a novel peptide, SA12, which showed significant activity in the inhibition of proliferation and induction of apoptosis in SKBr-3 breast cancer cells. The mechanism by which SA12 peptide triggers apoptosis was further investigated using a pull-down assay, reverse transcription-polymerase chain reaction, and Western blotting analysis. The results demonstrated that this peptide could interact with tumor-associated proteins MECP2 and CDC20B, which further induced apoptosis of tumor cells via the mitochondrial pathway involving the Bcl-2 family and related caspases. We propose that the novel SA12 peptide has the potential to provide a new strategy for the development of targeted therapy in breast cancer.
Keywords: targeted therapy, mRNA display, MECP2, Bcl-2, caspase






Download Article[PDF]